Cargando…

Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran

BACKGROUND: The incidence and associated risk factors for premature death were investigated in a population-based cohort study in Iran. METHODS: A total of 7245 participants (3216 men), aged 30–70 years, were included. We conducted Cox proportional hazards models to identify the risk factors for pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Eslami, Ali, Naghibi Irvani, Seyed Sina, Ramezankhani, Azra, Fekri, Nazanin, Asadi, Keyvan, Azizi, Fereidoun, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558847/
https://www.ncbi.nlm.nih.gov/pubmed/31182076
http://dx.doi.org/10.1186/s12889-019-7056-y
_version_ 1783425715137413120
author Eslami, Ali
Naghibi Irvani, Seyed Sina
Ramezankhani, Azra
Fekri, Nazanin
Asadi, Keyvan
Azizi, Fereidoun
Hadaegh, Farzad
author_facet Eslami, Ali
Naghibi Irvani, Seyed Sina
Ramezankhani, Azra
Fekri, Nazanin
Asadi, Keyvan
Azizi, Fereidoun
Hadaegh, Farzad
author_sort Eslami, Ali
collection PubMed
description BACKGROUND: The incidence and associated risk factors for premature death were investigated in a population-based cohort study in Iran. METHODS: A total of 7245 participants (3216 men), aged 30–70 years, were included. We conducted Cox proportional hazards models to identify the risk factors for premature death. For each risk factor, hazard ratio (HR), 95% confidence intervals (95% CI) and population attributable fraction (PAF) were calculated. RESULTS: After a median follow-up of 13.8 years, 262 premature deaths (153 in men) occurred. Underlying causes of premature deaths were cardiovascular disease (CVD) (n = 126), cancer (n = 51), road injuries (n = 15), sepsis and pneumonia (n = 9) and miscellaneous reasons (n = 61). The age-standardized incident rate of premature death was 2.35 per 1000 person years based on WHO standard population. Hypertension [HR 1.40, 95% CI (1.07–1.83)], diabetes (2.53, 1.94–3.29) and current smoking (1.58, 1.16–2.17) were significant risk factors for premature mortality; corresponding PAFs were 12.3, 22.4 and 9.2%, respectively. Overweight (body mass index (BMI): 25–29.9 kg/m(2)) (0.65, 0.49–0.87) and obesity (BMI ≥30 kg/m(2)) (0.67, 0.48–0.94) were associated with decreased premature mortality. After replacing general adiposity with central adiposity, we found no significant risk for the latter (0.92, 0.71–1.18). Moreover, when we excluded current smokers, those with prevalent cancer/cardiovascular disease and those with survival of less than 3 years, the inverse association between overweight (0.59, 0.39–0.88) and obesity (0.67, 0.43–1.04), generally remained unchanged; although, diabetes still showed a significant risk (2.62, 1.84–3.72). CONCLUSIONS: Controlling three modifiable risk factors including diabetes, hypertension and smoking might potentially reduce mortality events by over 40%, and among these, prevention of diabetes should be prioritized to decrease burden of events. We didn’t confirm a negative impact of overweight and obesity status on premature mortality events.
format Online
Article
Text
id pubmed-6558847
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65588472019-06-13 Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran Eslami, Ali Naghibi Irvani, Seyed Sina Ramezankhani, Azra Fekri, Nazanin Asadi, Keyvan Azizi, Fereidoun Hadaegh, Farzad BMC Public Health Research Article BACKGROUND: The incidence and associated risk factors for premature death were investigated in a population-based cohort study in Iran. METHODS: A total of 7245 participants (3216 men), aged 30–70 years, were included. We conducted Cox proportional hazards models to identify the risk factors for premature death. For each risk factor, hazard ratio (HR), 95% confidence intervals (95% CI) and population attributable fraction (PAF) were calculated. RESULTS: After a median follow-up of 13.8 years, 262 premature deaths (153 in men) occurred. Underlying causes of premature deaths were cardiovascular disease (CVD) (n = 126), cancer (n = 51), road injuries (n = 15), sepsis and pneumonia (n = 9) and miscellaneous reasons (n = 61). The age-standardized incident rate of premature death was 2.35 per 1000 person years based on WHO standard population. Hypertension [HR 1.40, 95% CI (1.07–1.83)], diabetes (2.53, 1.94–3.29) and current smoking (1.58, 1.16–2.17) were significant risk factors for premature mortality; corresponding PAFs were 12.3, 22.4 and 9.2%, respectively. Overweight (body mass index (BMI): 25–29.9 kg/m(2)) (0.65, 0.49–0.87) and obesity (BMI ≥30 kg/m(2)) (0.67, 0.48–0.94) were associated with decreased premature mortality. After replacing general adiposity with central adiposity, we found no significant risk for the latter (0.92, 0.71–1.18). Moreover, when we excluded current smokers, those with prevalent cancer/cardiovascular disease and those with survival of less than 3 years, the inverse association between overweight (0.59, 0.39–0.88) and obesity (0.67, 0.43–1.04), generally remained unchanged; although, diabetes still showed a significant risk (2.62, 1.84–3.72). CONCLUSIONS: Controlling three modifiable risk factors including diabetes, hypertension and smoking might potentially reduce mortality events by over 40%, and among these, prevention of diabetes should be prioritized to decrease burden of events. We didn’t confirm a negative impact of overweight and obesity status on premature mortality events. BioMed Central 2019-06-10 /pmc/articles/PMC6558847/ /pubmed/31182076 http://dx.doi.org/10.1186/s12889-019-7056-y Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Eslami, Ali
Naghibi Irvani, Seyed Sina
Ramezankhani, Azra
Fekri, Nazanin
Asadi, Keyvan
Azizi, Fereidoun
Hadaegh, Farzad
Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title_full Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title_fullStr Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title_full_unstemmed Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title_short Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
title_sort incidence and associated risk factors for premature death in the tehran lipid and glucose study cohort, iran
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558847/
https://www.ncbi.nlm.nih.gov/pubmed/31182076
http://dx.doi.org/10.1186/s12889-019-7056-y
work_keys_str_mv AT eslamiali incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT naghibiirvaniseyedsina incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT ramezankhaniazra incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT fekrinazanin incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT asadikeyvan incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT azizifereidoun incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran
AT hadaeghfarzad incidenceandassociatedriskfactorsforprematuredeathinthetehranlipidandglucosestudycohortiran